Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel
Journal cover image

Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale.

Publication ,  Journal Article
Faust-Socher, A; Anis, S; Kestenbaum, M; Shabtai, H; Taichman, T; Bar David, A; Ezra, A; Peretz, C; Rosenberg, A; Brozgol, M; Herman, T ...
Published in: Neuroepidemiology
2020

BACKGROUND: The Unified Dyskinesia Rating Scale (UDysRS) is a well-established tool for producing comprehensive assessments of severity and disability associated with dyskinesia in patients with Parkinson's disease (PD). The scale was originally developed in English, and a broad international effort has been undertaken to develop and validate versions in additional languages. Our aim was to validate the Hebrew version of the UDysRS. METHODS: We translated the UDysRS into Hebrew, back-translated it into English, and carried out cognitive pretesting. We then administered the scale to non-demented native Hebrew-speaking patients who fulfilled the Brain Bank diagnostic criteria for probable PD (n = 250). Data were compared to the Reference Standard data used for validating UDysRS translations. RESULTS: The different portions of the Hebrew UDysRS showed high internal consistency (α ≥ 0.92). A confirmatory factor analysis in which we compared the Hebrew UDysRS to the Reference Standard version produced a comparative fit index (CFI) of 0.98, exceeding the threshold criterion of CFI > 0.9 indicating factor validity. A secondary exploratory factor analysis provided further support to the consistency between the factor structures of the Hebrew and Reference Standard versions of the UDysRS. CONCLUSION: The UDysRS Hebrew version shows strong clinimetric properties and fulfills the criteria for designation as an official International Parkinson and Movement Disorder Society-approved translation for use in clinical and research settings.

Duke Scholars

Published In

Neuroepidemiology

DOI

EISSN

1423-0208

Publication Date

2020

Volume

54

Issue

4

Start / End Page

356 / 362

Location

Switzerland

Related Subject Headings

  • Severity of Illness Index
  • Reproducibility of Results
  • Psychometrics
  • Parkinson Disease
  • Middle Aged
  • Male
  • Israel
  • Humans
  • Female
  • Epidemiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Faust-Socher, A., Anis, S., Kestenbaum, M., Shabtai, H., Taichman, T., Bar David, A., … Gurevich, T. (2020). Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale. Neuroepidemiology, 54(4), 356–362. https://doi.org/10.1159/000507827
Faust-Socher, Achinoam, Saar Anis, Meir Kestenbaum, Herzl Shabtai, Tali Taichman, Aya Bar David, Adi Ezra, et al. “Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale.Neuroepidemiology 54, no. 4 (2020): 356–62. https://doi.org/10.1159/000507827.
Faust-Socher A, Anis S, Kestenbaum M, Shabtai H, Taichman T, Bar David A, et al. Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale. Neuroepidemiology. 2020;54(4):356–62.
Faust-Socher, Achinoam, et al. “Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale.Neuroepidemiology, vol. 54, no. 4, 2020, pp. 356–62. Pubmed, doi:10.1159/000507827.
Faust-Socher A, Anis S, Kestenbaum M, Shabtai H, Taichman T, Bar David A, Ezra A, Peretz C, Rosenberg A, Brozgol M, Herman T, Stebbins GT, Goetz CG, Martínez-Martín P, Luo ST, Ren X, Giladi N, Gurevich T. Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale. Neuroepidemiology. 2020;54(4):356–362.
Journal cover image

Published In

Neuroepidemiology

DOI

EISSN

1423-0208

Publication Date

2020

Volume

54

Issue

4

Start / End Page

356 / 362

Location

Switzerland

Related Subject Headings

  • Severity of Illness Index
  • Reproducibility of Results
  • Psychometrics
  • Parkinson Disease
  • Middle Aged
  • Male
  • Israel
  • Humans
  • Female
  • Epidemiology